Pharmspective Launches AccessAI Market Access Artificial Intelligence Platform

 


Pharmspective LLC has introduced AccessAI™, an innovative AI tool designed to simplify the acquisition of Market Access knowledge for the biopharmaceutical industry. AccessAI™ (https://access-ai.net/) leverages a foundation of over 12,000 references from daily-updated data sources covering aspects like insurers, reimbursement, distribution, payment models, policy, and access dynamics affecting pharmaceutical manufacturers. The tool seamlessly integrates AI technology with expert knowledge, enabling on-demand research into market access challenges for pharmaceutical decision-makers.

Nicole Espinoza, Vice-President of Knowledge Management, highlights AccessAI™ as a solution to outdated secondary research methods, offering a more efficient and cost-effective approach to obtaining critical market access insights. The web-enabled, subscription-based portal provides a user-friendly interface akin to standard AI platforms. To enhance AccessAI™, the company has established a dedicated Content Management team to assist clients in maximizing the platform's value across various organizational units.

Laurie Blunt, Director of Content Acquisition, underscores AccessAI™ as an exemplary use of AI chatbots for efficiency. By connecting AccessAI™'s generative content capability to credible market access data sources, the tool produces exceptional market research at a fraction of the time and cost associated with traditional secondary research approaches. AccessAI™ stands as a pioneering AI solution, leveraging recent advances to deliver faster, more accurate market access knowledge for the pharmaceutical industry.

Read More - https://www.techdogs.com/tech-news/pr-newswire/pharmspective-launches-accessai-market-access-artificial-intelligence-platform

Comments

Popular posts from this blog

Orlagh Neary, Former VP Of Quantum Ecosystem Engagement And GTM At Microsoft On Building Scalable And Safe AI And Quantum

Varun Srinivas Founder & CEO of Therix.ai and Co-Founder at Coditas on Building Real-World AI Solutions

MediaTek Vs. Snapdragon: Which Chipset Performs Better?